Lilly(Eli) & Company
NYSE: LLY
$819.36
+$7.33 (+0.9%)
Closing Price on June 13, 2025
LLY Articles
The stock market has been on edge since the announcement of tariffs, reporting its biggest loss since March 2020. The damage continues and about 80% of the S&P 500 companies were in red this...
Published:
Dividend stocks have been a reliable cornerstone for those who want to anchor their portfolios when markets get shaky. These stocks give you a steady stream of income and often appreciate during...
Published:
Stock splits tend to create a lot of buzz in the market, especially when some of the most prominent companies announce a split. Whenever the stock prices hit a higher range, the management decides to...
Published:
The Food & Drug Administration announced last week that the Ozempic and Wegovy shortage for Novo Nordisk‘s (NYSE:NVO) was over. It said the Danish pharmaceutical had sufficient supply of its...
Published:
The big pharma sector is one that’s generally fallen out of favor for many investors over the past few decades, as large healthcare companies have seen slower growth and consolidation hasn’t...
Published:
Shares of Hims & Hers Health (NYSE:HIMS) are down about 21%, or $14. All on news the Ozempic shortage is over. About This Article Just this morning, the US FDA said Novo Nordisk’s popular...
Published:
President Trump is going scorched earth on America’s major European trading partners. Vowing to impose reciprocal tariffs on “every country” that hits U.S. products coming into their countries...
Published:
AbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50 years.
Published:
Finding stocks with the potential to double in just three years is no easy feat, even in this bull market. Plenty of companies have accomplished this feat in the recent past, and I’m going to...
Published:
Live Updates Live Coverage Has Ended Deep Dive into ABBV's Earnings Call 11:53 am by Rich Duprey Looking through AbbVie’s earnings call, these growth prospects stood out: 1. Skyrizi & Rinvoq...
Published:
The biotech scene can be seen as fairly risky for new investors who want to put money to work. After all, it’s really tough to gauge which innovative biotech firms will have something genuinely...
Published:
Eli Lilly (NYSE: LLY) doesn’t really need much of an introduction. It has become a household name due to its obesity and diabetes treatments. LLY stock has delivered exponential returns from 2018...
Published:
Last Updated:
Palantir Technologies (NASDAQ:PLTR) has been described as the best pure-play stock in artificial intelligence. The market agrees, sending shares of PLTR stock some 342% higher over the past year, far...
Published:
Last Updated:
Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli Lilly (NYSE:LLY) has become the industry leader in a class of drugs called...
Published:
Live Updates Live Coverage Has Ended Momentum Stocks Crash 3:53 pm by Eric Bleeker As we near the closing bell, major indexes are generally flat today. The Nasdaq is down .12%, while the S&P 500...
Published:
Last Updated:
